Federal Circuit Affirms Judgment that Swiss Pharma Company Did Not Infringe Iron Deficiency Therapy Patent Claims

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in Biofer S.p.A. v. Vifor (International) AG affirming a judgment of non-infringement by the U.S. District Court for the Eastern District of New York in favor of Swiss Pharmaceutical company, Vifor (International) AG. The dispute centered on the construction of a claimed pH range recited in a patent covering a process for producing iron-sugar complexes used to treat iron deficiency. The post Federal Circuit Affirms